PTAB challenges

Proceedings overview

There is one active AIA trial proceeding on US patent 10578818. This IPR proceeding has been instituted, meaning trial is underway. The patent's claims are currently undergoing review, which may result in cancellation or sustenance of claims. This ongoing challenge means the patent's validity is still in question.

IPR2026-00094 — Eoptolink Technology USA Inc. et al. v. Applied Optoelectronics Inc.

• Type: Inter Partes Review
• Filed: 2025-11-05
• Status: Trial Instituted (as of 2026-04-13), indicating the PTAB has determined there is a reasonable likelihood that at least one challenged claim is unpatentable, and the trial phase has begun.
• Judge panel: Information not publicly available at this time from general search results. I would need access to the specific PTAB End-to-End (E2E) system for IPR2026-00094 to identify the panel members.
• Petition grounds: Information regarding specific claims challenged, prior art asserted, and statutory bases (§ 102 / § 103 / § 112) is not available from public search summaries. This detail would be contained within the petition and institution decision, accessible via the PTAB E2E system.
• Institution decision: Instituted on 2026-04-13. The PTAB found a reasonable likelihood that at least one claim challenged in the petition is unpatentable, leading to the institution of the inter partes review.
• Final Written Decision (if issued): Not yet issued. The proceeding is currently in the trial phase.
• Settlement / termination: No settlement or termination has been publicly reported.
• Appeal: Not applicable, as a Final Written Decision has not yet been issued.
• Defensive value: This proceeding indicates that at least some claims of US10578818 are actively being challenged for patentability. Until a Final Written Decision is issued, the validity of the challenged claims remains uncertain, which introduces risk for any assertion based on them. If a defendant is facing assertions based on claims being challenged in IPR2026-00094, this ongoing trial offers potential leverage.

Strategic summary

As of the current date, only one AIA trial proceeding, IPR2026-00094, has been initiated against US patent 10578818. This IPR is currently in the "Trial Instituted" status, meaning the PTAB has agreed to review the patentability of certain claims based on the petitioner's arguments and prior art. Consequently, all claims of US10578818 challenged in this IPR are currently UNTESTED until a Final Written Decision is rendered. No claims have been canceled or sustained through a FWD at this point.

Regarding the estoppel landscape, once a Final Written Decision is issued in IPR2026-00094, the petitioner (Eoptolink Technology USA Inc. et al.) and their privies will be estopped under § 315(e)(2) from asserting invalidity grounds that they raised or reasonably could have raised in the IPR. For a defendant currently facing assertion of this patent, prior-art grounds not raised or reasonably raisable by Eoptolink, or grounds related to claims not challenged in the IPR, would still be available. The patent owner, Applied Optoelectronics Inc., has had the patent assigned to them on 2024-11-14. The petitioner for IPR2026-00094 is "Unified Patents PTAB Data" by Unified Patents. This suggests a potential defensive aggregator is involved in challenging the patent.

Recommended next steps

• Since IPR2026-00094 has been instituted, it is crucial to monitor its progress. The PTAB has a statutory one-year deadline to issue a Final Written Decision from the date of institution (April 13, 2026). Therefore, a Final Written Decision is anticipated by approximately April 13, 2027. Key milestones to watch for include scheduling orders, potential oral hearings, and the eventual FWD.
• For detailed information on the claims challenged, prior art grounds, and specific reasoning for institution in IPR2026-00094, access the official PTAB End-to-End (E2E) system directly for case IPR2026-00094 (https://portal.unifiedpatents.com/ptab/case/IPR2026-00094 is provided in the patent information). This will provide the petition, the institution decision, and all subsequent filings.
• If you are a defendant, assess whether your potentially infringing products or methods rely on claims currently under review in IPR2026-00094. The outcome of this IPR could significantly impact the strength of any infringement allegations.